IDEAS home Printed from https://ideas.repec.org/p/fip/fedbcq/2019_002.html
   My bibliography  Save this paper

Access to medication-assisted treatment for opioid use disorder: is Rhode Island different, and why?

Author

Listed:
  • Mary A. Burke

Abstract

This paper assesses the prevalence of medication-assisted treatment (MAT) among treatment episodes for opioid use disorder (OUD) in Rhode Island, as compared with the remaining New England states and the United States as a whole. Based on the Treatment Episode Data Set (TEDS-A), a national census of admissions into publicly funded treatment facilities for substance use disorders, we find that during the period beginning in 2000 through 2017, Rhode Island exhibited a greater tendency to use MAT as part of OUD treatment compared with the average state in the United States and compared with the average combined tendency among the five other New England states. Logistic regression analysis reveals that the higher incidence of MAT among OUD treatment episodes in Rhode Island compared with the US average can be partly accounted for by Rhode Island?s having (1) a higher share of patients with government-sponsored health insurance plans, (2) an older age profile of patients, (3) a higher share of married patients, and (4) a higher percentage of intravenous drug users. However, well over half of the difference in the MAT rate between Rhode Island and rest of the United States is due to differences in factors not observed in the TEDS-A but which are known to prevail in the state, such as Rhode Island?s high number of methadone clinics per capita, its high federal funding rate per capital to combat substance abuse, and state policies promoting the use of MAT.

Suggested Citation

  • Mary A. Burke, 2019. "Access to medication-assisted treatment for opioid use disorder: is Rhode Island different, and why?," Current Policy Perspectives 19-2, Federal Reserve Bank of Boston.
    • Handle: RePEc:fip:fedbcq:2019_002
    as

    Download full text from publisher

    File URL: https://www.bostonfed.org/-/media/Documents/Workingpapers/PDF/2019/cpp1902.pdf
    File Function: Full text
    Download Restriction: no
    File URL: https://www.bostonfed.org/publications/current-policy-perspectives/2019/access-to-medication-assisted-treatment-for-opioid-use-disorder.aspx
    File Function: Summary
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Joyce Manchester & Riley Sullivan, 2019. "Exploring causes of and responses to the opioid epidemic in New England," New England Public Policy Center Policy Reports 19-2, Federal Reserve Bank of Boston.
    2. Johanna Catherine Maclean & Brendan Saloner, 2019. "The Effect of Public Insurance Expansions on Substance Use Disorder Treatment: Evidence from the Affordable Care Act," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 38(2), pages 366-393, March.
    3. Jones, C.M. & Campopiano, M. & Baldwin, G. & McCance-Katz, E., 2015. "National and state treatment need and capacity for opioid agonist medication-assisted treatment," American Journal of Public Health, American Public Health Association, vol. 105(8), pages 55-63.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Mary A. Burke & Katherine Grace Carman & Riley Sullivan & Hefei Wen & James Frank Wharam & Hao Yu, 2021. "Did the Affordable Care Act Affect Access to Medications for Opioid Use Disorder among the Already Insured? Evidence from the Rhode Island All-payer Claims Database," Working Papers 21-17, Federal Reserve Bank of Boston.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Mary A. Burke & Riley Sullivan, 2020. "Medication-assisted Treatment for Opioid Use Disorder in Rhode Island: Who Gets Treatment, and Does Treatment Improve Health Outcomes?," New England Public Policy Center Research Report 20-3, Federal Reserve Bank of Boston.
    2. Matthew T. Knowles, 2022. "How access to addictive drugs affects the supply of substance abuse treatment: Evidence from Medicare Part D," Health Economics, John Wiley & Sons, Ltd., vol. 31(8), pages 1649-1675, August.
    3. Mary A. Burke & Katherine Grace Carman & Riley Sullivan & Hefei Wen & James Frank Wharam & Hao Yu, 2021. "Who Gets Medication-assisted Treatment for Opioid Use Disorder, and Does It Reduce Overdose Risk? Evidence from the Rhode Island All-payer Claims Database," Working Papers 21-3, Federal Reserve Bank of Boston.
    4. Aparna Soni & Lindsey Bullinger & Christina Andrews & Amanda Abraham & Kosali Simon, 2024. "The impact of state Medicaid eligibility and benefits policy on neonatal abstinence syndrome hospitalizations," Contemporary Economic Policy, Western Economic Association International, vol. 42(1), pages 25-40, January.
    5. Meinhofer, Angélica & Witman, Allison E., 2018. "The role of health insurance on treatment for opioid use disorders: Evidence from the Affordable Care Act Medicaid expansion," Journal of Health Economics, Elsevier, vol. 60(C), pages 177-197.
    6. Ellen Bouchery & Judith Dey, "undated". "Substance Use Disorder Workforce," Mathematica Policy Research Reports 47d4d14a7a32485eba249dfb3, Mathematica Policy Research.
    7. Isaac, Elliott & Jiang, Haibin, 2022. "Tax-Based Marriage Incentives in the Affordable Care Act," IZA Discussion Papers 15331, Institute of Labor Economics (IZA).
    8. Jayme E. Walters & Aubrey E. Jones & Aaron R. Brown & Dorothy Wallis, 2022. "Impacts of the COVID-19 Pandemic on a Rural Opioid Support Services Program," IJERPH, MDPI, vol. 19(18), pages 1-12, September.
    9. Scott Barkowski & Joanne Song McLaughlin & Alex Ray, 2020. "A Reevaluation of the Effects of State and ACA Dependent Coverage Mandates on Health Insurance Coverage," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 39(3), pages 629-663, June.
    10. Mukhopadhyay, Sankar, 2022. "The Effects of Medicaid Expansion on Job Loss Induced Mental Distress during the COVID-19 Pandemic in the US," IZA Discussion Papers 15150, Institute of Labor Economics (IZA).
    11. David Powell & Rosalie Liccardo Pacula, 2021. "The Evolving Consequences of OxyContin Reformulation on Drug Overdoses," American Journal of Health Economics, University of Chicago Press, vol. 7(1), pages 41-67.
    12. Hamersma, Sarah & Maclean, Johanna Catherine, 2021. "Do expansions in adolescent access to public insurance affect the decisions of substance use disorder treatment providers?," Journal of Health Economics, Elsevier, vol. 76(C).
    13. Johanna Catherine Maclean & Brendan Saloner, 2019. "The Effect of Public Insurance Expansions on Substance Use Disorder Treatment: Evidence from the Affordable Care Act," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 38(2), pages 366-393, March.
    14. Maclean, Johanna Catherine & Tello-Trillo, Sebastian & Webber, Douglas, 2023. "Losing insurance and psychiatric hospitalizations," Journal of Economic Behavior & Organization, Elsevier, vol. 205(C), pages 508-527.
    15. Alberto Ortega, 2023. "Medicaid Expansion and mental health treatment: Evidence from the Affordable Care Act," Health Economics, John Wiley & Sons, Ltd., vol. 32(4), pages 755-806, April.
    16. Lindsey Rose Bullinger, 2021. "Child Support and the Affordable Care Act's Medicaid Expansions," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 40(1), pages 42-77, January.
    17. Mitchell, Penelope & Samsel, Steven & Curtin, Kevin M. & Price, Ashleigh & Turner, Daniel & Tramp, Ryan & Hudnall, Matthew & Parton, Jason & Lewis, Dwight, 2022. "Geographic disparities in access to Medication for Opioid Use Disorder across US census tracts based on treatment utilization behavior," Social Science & Medicine, Elsevier, vol. 302(C).
    18. Aparna Soni, 2020. "The effects of public health insurance on health behaviors: Evidence from the fifth year of Medicaid expansion," Health Economics, John Wiley & Sons, Ltd., vol. 29(12), pages 1586-1605, December.
    19. Alice M. Ellyson & Jevay Grooms & Alberto Ortega, 2022. "Flipping the script: The effects of opioid prescription monitoring on specialty‐specific provider behavior," Health Economics, John Wiley & Sons, Ltd., vol. 31(2), pages 297-341, February.
    20. Michael R. Richards & Sebastian Tello‐Trillo, 2021. "Private coverage mandates, business cycles, and provider treatment intensity," Health Economics, John Wiley & Sons, Ltd., vol. 30(5), pages 1200-1221, May.

    More about this item

    Keywords

    opioid use disorder; treatment episode data set; medication-assisted treatment; Rhode Island;
    All these keywords.

    JEL classification:

    • I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health
    • I12 - Health, Education, and Welfare - - Health - - - Health Behavior
    • I13 - Health, Education, and Welfare - - Health - - - Health Insurance, Public and Private

    NEP fields

    This paper has been announced in the following NEP Reports:

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:fip:fedbcq:2019_002. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Spozio (email available below). General contact details of provider: https://edirc.repec.org/data/frbbous.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.